Atlas Trials

Comparing Post-intravitreal Injection Pain Scores Using Loteprednol, Bromfenac Sodium, and Artificial Tears Over a 24-hour Period

Clinical trial NCT07090044 · COMPLETED

Trial details

NCT number
NCT07090044
Sponsor
Retina Research Institute, LLC
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Vein OcclusionMacular Degeneration Choroidal NeovascularizationMacular EdemaDiabetic Retinopathy
Start date
2021-08-20
Primary completion
2022-12-07
Enrollment
77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.